Supervision and Administration Bureau, the information on the results of the food safety sampling inspection organized by our bureau is hereby announced as follows:
Over 1 billion contrast agents!
Time of Update: 2022-05-22
com, the sales of terminal iopromide injection in Chinese public medical institutions will exceed 1 billion yuan in 2020, and the first half of 2021 will increase by more than 20% year-on-year .
Guangzhou Petrochemical continues to optimize and improve the purity of butene-1 products
Time of Update: 2022-05-22
the main reason for the decline in the conversion rate of isobutene: the flow of vapor and liquid phases in the catalytic distillation column bed The space increases, the pressure difference decreases, the reaction contact residence time of methanol
Scientists discover anti-HIV-1 antibody treatment suppresses viral infection
Time of Update: 2022-05-21
rebound virus . The study found that post-hoc sensitivity analyses did not predict when the virus would rebound . In individuals whose
The next round of competition for domestic PD-1 is shifting to overseas markets
Time of Update: 2022-05-20
On April 13, 2022, Junshi Bio announced that toripalimab, an anti-PD-1 monoclonal antibody independently developed by the company for the treatment of small cell lung cancer (SCLC), has been approved by the U.
One picture to understand 13 PD-1/PD-L1 drugs approved in China
Time of Update: 2022-05-20
>released in 2021, is liked by many readers. After 4 months, a remake version will be released. The update date is as of April 28, 2022. Follow China's PD
First completed the administration of the first subject of the Phase I clinical trial for the oral preparation of GLP-1 polypeptide XW004
Time of Update: 2022-05-20
Pan Hai, founder and CEO of Xianweida, said, "The initiation of this Phase 1 MAD clinical study is the first step in developing XW004 as a safe and effective therapy for patients with metabolic diseases .
Pemetrexed: Folic acid and VB12 applied 1 week in advance or at the same time?
Time of Update: 2022-05-20
Timing offolic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial.
Uric acid less than 1 μmol/L?
Time of Update: 2022-05-19
>foreword>forewordUric acid is the final product of purine metabolism, produced by xanthine
Vietnam's monthly export of aquatic products reaches 1 billion US dollars
Time of Update: 2022-05-19
Vietnam Herald website reported on April 27, 2022, according to data from Vietnam Association of Aquatic Products
Diabetologia: Early and late histological confirmation of celiac disease in children with new-onset type 1 diabetes
Time of Update: 2022-05-19
>>Table 1 Adjusted outcome variables for participants with early versus delayed histological diagnosis of celiac disease (n = 411) at the last follow-up visit>>Figure 2 SDS
"Cold" tumor becomes "hot" Oncolytic virus/CAR-T combination therapy Phase 1 clinical trial is about to start
Time of Update: 2022-05-19
April 18, 2022, from https://ir . mustangbio. com/news-events/press-releases/detail/137/mustang-bio-announces-a-phase-1-clinical-trial-combining>
NICE recommends Koselugo for neurofibromatosis type 1
Time of Update: 2022-05-18
Therefore, this Phase II trial concluded that most children with neurofibromatosis type 1 and inoperable plexiform neurofibromas experienced significant clinical benefit with Koselugo .
with pembrolizumab in patients with advanced melanoma resistant to PD-1 immunotherapy
Time of Update: 2022-05-18
This is a single-arm study (NCT04570332) of intratumoral BO-112 and intravenous pembrolizumab in patients with melanoma (skin, condyloma, or mucosa) receiving anti-PD1 therapy and confirmed progressive disease (PD) .
Nippon Paint Ranked No. 1 in China's Brand Power Index
Time of Update: 2022-05-17
On April 20, Nippon Paint China announced that in the 2022 (12th) China Brand Value Index Brand Ranking and Analysis Report released by the brand rating authority Chnbrand, Nippon Paint Wall
The large variety of anti-gout was "cut in half", and 4 new drugs of class 1 of traditional Chinese medicine were strongly filled
Time of Update: 2022-05-17
Figure 1: Market size of chemical anti-gout preparations in recent years (unit: 100 million yuan) Source: Minet.
Diabetologia: Characteristics of Type 1 Diabetes and Refractory Hypoglycemia in Adults
Time of Update: 2022-05-17
AHN, normalization of asymptomatic hypoglycemia; HAP, avoidance of hyperglycemia prioritized; HCM, minimized hypoglycemia problems;Figure 2 k-means cluster analysis of the HARPdoc cohort with two clusters .
